Authors: Aoyama, Y Uenaka, M Kii, M Tanaka, M Konoike, T Hayasaki-Kajiwara, Y Naya, N Nakajima, M

Citation: Y. Aoyama et al., Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors, BIO MED CH, 9(11), 2001, pp. 3065-3075

Authors: Shimodera, S Inoue, S Mino, Y Tanaka, S Kii, M Motoki, Y

Citation: S. Shimodera et al., Expressed emotion and psychoeducational intervention for relatives of patients with schizophrenia: a randomized controlled study in Japan, PSYCHIAT R, 96(2), 2000, pp. 141-148

Authors: Seno, K Okuno, T Nishi, K Murakami, Y Watanabe, F Matsuura, T Wada, M Fujii, Y Yamada, M Ogawa, T Okada, T Hashizume, H Kii, M Hara, S Hagishita, S Nakamoto, S Yamada, K Chikazawa, Y Ueno, M Teshirogi, I Ono, T Ohtani, M

Citation: K. Seno et al., Pyrrolidine inhibitors of human cytosolic phospholipase A(2), J MED CHEM, 43(6), 2000, pp. 1041-1044

Authors: Murakami, Y Hagishita, S Okada, T Kii, M Hashizume, H Yagami, T Fujimoto, M

Citation: Y. Murakami et al., 1,3-disubstituted benzazepines as neuropeptide YY1 receptor antagonists, BIO MED CH, 7(8), 1999, pp. 1703-1714

Authors: Murakami, Y Hara, H Okada, T Hashizume, H Kii, M Ishihara, Y Ishikawa, M Shimamura, M Mihara, S Kato, G Hanasaki, K Hagishita, S Fujimoto, M

Citation: Y. Murakami et al., 1,3-disubstituted benzazepines as novel, potent, selective neuropeptide YY1 receptor antagonists, J MED CHEM, 42(14), 1999, pp. 2621-2632